4.7 Review

Oxidized Albumin as a Mediator of Kidney Disease

期刊

ANTIOXIDANTS
卷 10, 期 3, 页码 -

出版社

MDPI
DOI: 10.3390/antiox10030404

关键词

oxidized albumin; obesity; kidney disease

资金

  1. Fondo Nacional de Desarrollo Cientifico y Tecnologico (Fondecyt) [1201251]
  2. Fondecyt [3201016]
  3. National Autonomous University of Mexico-DGAPA-PAPIIT [IN202919]

向作者/读者索取更多资源

Overweight and obesity are common in kidney disease patients, and are associated with oxidative stress and increased urinary albumin excretion, leading to higher cardiovascular risk. Oxidized albumin levels correlate with decreased kidney function and increased blood urea nitrogen, and have a direct effect on neutrophils.
Renal diseases are a global health concern, and nearly 24% of kidney disease patients are overweight or obese. Particularly, increased body mass index has been correlated with oxidative stress and urinary albumin excretion in kidney disease patients, also contributing to increased cardiovascular risk. Albumin is the main plasma protein and is able to partially cross the glomerular filtration barrier, being reabsorbed mainly by the proximal tubule through different mechanisms. However, it has been demonstrated that albumin suffers different posttranslational modifications, including oxidation, which appears to be tightly linked to kidney damage progression and is increased in obese patients. Plasma-oxidized albumin levels correlate with a decrease in estimated glomerular filtration rate and an increase in blood urea nitrogen in patients with chronic kidney disease. Moreover, oxidized albumin in kidney disease patients is independently correlated with higher plasma levels of transforming growth factor beta (TGF-beta 1), tumor necrosis factor (TNF-alpha), and interleukin (IL)-1 beta and IL-6. In addition, oxidized albumin exerts a direct effect on neutrophils by augmenting the levels of neutrophil gelatinase-associated lipocalin, a well-accepted biomarker for renal damage in patients and in different experimental settings. Moreover, it has been suggested that albumin oxidation occurs at early stages of chronic kidney disease, accelerating the patient requirements for dialytic treatment during disease progression. In this review, we summarize the evidence supporting the role of overweight- and obesity-induced oxidative stress as a critical factor for the progression of renal disease and cardiovascular morbimortality through albumin oxidation.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据